Chia-yu Y. Chu
No. 7, Chung Shan South Road
TPQ, Taiwan
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 174 publications
Redefining Treat-to-target in Atopic Dermatitis: Towards Meaningful, Patient-centred Disease Control - An ISAD Position Paper.
Journal: Acta dermato-venereologica
Published: July 16, 2026
Redefining Treat-to-target in Atopic Dermatitis: Towards Meaningful, Patient-centred Disease Control - An ISAD Position Paper.
Journal: Acta dermato-venereologica
Published: July 16, 2026
A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence.
Journal: Dermatology and therapy
Published: March 08, 2026
Clinical and Pathological Predictors of Unfavourable Outcomes in Thin and In Situ Melanomas: A Retrospective Cohort Study from Taiwan.
Journal: Acta dermato-venereologica
Published: March 02, 2026
Uncovering a Dual Th17/Type 2 Transcriptomic Endotype in Psoriasis.
Journal: Journal of the American Academy of Dermatology
Published: February 02, 2026
Managing Skin Side Effects Associated With Oncology Treatments: Asian Perspective on Use of Dermocosmetics.
Journal: Asia-Pacific journal of clinical oncology
Published: January 07, 2026
HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactions.
Journal: The Journal of allergy and clinical immunology
Published: December 05, 2025
Darier disease-A review highlighting new insights from the Darier Disease International Task Force.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 24, 2025
Disseminated herpes simplex virus type 2 infection manifesting as cutaneous vasculitis: A case report.
Journal: JAAD case reports
Published: November 11, 2025
Hematological inflammatory biomarkers as predictors of the severity and outcomes of bullous pemphigoid: A retrospective cohort study.
Journal: JAAD international
Published: October 27, 2025
Use of Baricitinib in Patients With TIF1-γ Positive Dermatomyositis Following a COVID-19 Infection.
Journal: Experimental dermatology
Published: October 18, 2025
Last Updated: 09/26/2026